3 years ago
MRNA
AnalystsEmmanuel PapadakisEmmanuel Papadakis's Stock Forecasts
AnalystsEmmanuel Papadakis
Analyst Ranking
Bottom 30%
#3447 out of 4866 analysts
Average Return
-1.42%
Win Rate
50%4 out of 8
Risk vs Reward
Poor
Good
Emmanuel Papadakis's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Biontech SeBNTX | +44.90% | $79.25 | $114.83 | 2024-08-07 - 2025-04-23 | Strong Buy |
Novartis AgNVS | +2.50% | $82.80 | $80.73 | 2021-09-20 - 2022-09-19 | Strong Sell |
Biontech SeBNTX | +2.06% | $112.51 | $114.83 | 2024-09-19 - 2025-04-23 | Strong Buy |
Novartis AgNVS | +0.69% | $81.36 | $80.80 | 2017-10-25 - 2018-07-19 | Strong Sell |
Emmanuel Papadakis Analyst Color
Get additional color on Emmanuel Papadakis's coverage of popular stocks
Emmanuel Papadakis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biontech SeBNTX | 9 | Strong Buy | $150.00 | +30.63% | Maintains | 7 months ago |
Moderna IncMRNA | 6 | Hold | $80.00 | +201.43% | Upgrades | 9 months ago |
AlvotechALVO | 2 | Hold | $12.00 | N/A | Maintains | 2 years ago |
SanofiSNY | 3 | Hold | N/A | N/A | Upgrades | 3 years ago |
Curevac NvCVAC | 1 | Hold | $35.00 | N/A | Initiates Coverage On | 4 years ago |
Novartis AgNVS | 4 | Strong Sell | N/A | N/A | Downgrades | 4 years ago |
Argenx SeARGX | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Ucb SaUCBJY | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Roche Holding LtdRHHBY | 1 | Strong Buy | N/A | N/A | Upgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.